Examples of using Benlysta in English and their translations into Polish
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Financial
-
Official/political
-
Programming
-
Computer
Amount of Benlysta.
Benlysta is administered by intravenous infusion.
How does Benlysta work?
How to reconstitute Benlysta.
How has Benlysta been studied?
How to store Benlysta.
Benlysta contains belimumab a monoclonal antibody.
Before diluting Benlysta.
After this, Benlysta is usually given once every 4 weeks.
There is limited clinical experience with overdose of Benlysta.
Benlysta must not be administered as an intravenous bolus.
Serious infections occurred in 5% of patients receiving Benlysta or placebo.
Benlysta is not usually recommended if you are pregnant.
Glucose intravenous solutions are incompatible with Benlysta and must not be used.
Benlysta is given as an infusion(drip) into a vein over one hour.
Opportunistic infections have been reported in patients treated with Benlysta.
Benlysta 120 mg powder for concentrate for solution for infusion Belimumab.
The combination of such medicines together with Benlysta may make your immune system less effective.
Benlysta can cause a reaction to the infusion or an allergic(hypersensitivity) reaction.
Progressive multifocal leukoencephalopathy(PML) has been reported with Benlysta treatment for SLE.
The risk of using Benlysta in patients with active or latent tuberculosis is unknown.
Your chance of getting PML may be higher if you are treated with medicines thatweaken your immune system, including Benlysta.
No incompatibilities between Benlysta and polyvinylchloride or polyolefin bags have been observed.
Benlysta contains less than 1 mmol sodium(23 mg) in each dose and therefore is essentially sodium-free.
A nurse or doctor will give you Benlysta through a drip in your vein(intravenous infusion) over one hour.
Benlysta has not been studied in the following patient groups, and is not recommended in.
The company will provide further information on the safety of Benlysta from a study and from a register of patients being followed up long-term.
Benlysta should not be used during pregnancy unless the potential benefit justifies the potential risk to the foetus.
It is unknown whether Benlysta is excreted in human milk or is absorbed systemically after ingestion.
Benlysta treatment should be initiated and supervised by a qualified physician experienced in the diagnosis and treatment of SLE.